Type-2 Diabetes [clinicaltrials_resource:a93a42f8a1fb226472ca5c605bedb639]
Hepatocyte Growth Factor and Cardiovascular Autonomic Function [clinicaltrials:NCT00478127]Pharmacokinetic Study of Vildagliptin in Patients With Renal Impairment [clinicaltrials:NCT00567047]Effect of LAF237 on Glucagon Secretion in Patients With Type 2 Diabetes and in Healthy Subjects [clinicaltrials:NCT00651105]Nutritional Intervention With Moderately High-protein, Low-glycemic Load Products in Type-2 Diabetes Patients [clinicaltrials:NCT01264523]Effects of Milk Derived From Mountain-pasture Grazing Cows on Risk Markers of the Metabolic Syndrome Compared to Conventional Danish Milk [clinicaltrials:NCT01343589]Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) [clinicaltrials:NCT01440660]Liraglutide and Cardio-Metabolic Risk Markers [clinicaltrials:NCT01715428]Walnuts and Glucose Variability [clinicaltrials:NCT01787214]Diabetes Risk Assessment Study [clinicaltrials:NCT01884714]Dietary Intervention Replacing Carbohydrate With Protein and Fat Has Greater Effect on Peripheral Blood Mononuclear Cell Metabolites Than on Plasma Metabolites in Patients With Prediabetes or Type-2 Diabetes [clinicaltrials:NCT02191644]
condition [clinicaltrials_vocabulary:condition]
Type-2 Diabetes [clinicaltrials_resource:a93a42f8a1fb226472ca5c605bedb639]
Bio2RDF identifier
a93a42f8a1fb226472ca5c605bedb639
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a93a42f8a1fb226472ca5c605bedb639
identifier
clinicaltrials_resource:a93a42f8a1fb226472ca5c605bedb639
title
Type-2 Diabetes
@en
label
Type-2 Diabetes [clinicaltrials_resource:a93a42f8a1fb226472ca5c605bedb639]
@en